Analytical Bioventures S.C.A., a company controlled by Eurofins Scientific CEO Dr. Gilles Martin, acquired a total of 3,000 shares of Eurofins Scientific across three transactions on the Euronext Paris exchange. The purchases were made on June 25 at EUR 67.7737 per share, June 26 at EUR 68.4577 per share, and June 29 at EUR 68.4011 per share, for an aggregated total of EUR 204,632.50. The notifications were made in accordance with the European Market Abuse Regulation.
Eurofins Scientific SECEO-controlled entity buys shares, signaling insider confidence.